Prebiotic chew for enhancing pet oral health

Technology
In development
University

Introducing a prebiotic chew for pets that supports oral health by reducing harmful bacteria while maintaining beneficial microbes. This chew provides a safe alternative to brushing, addressing plaque buildup and bad breath through functional ingredients like L-arginine and coconut oil.

Overview

The prebiotic chew for pets is a breakthrough innovation designed to naturally enhance oral health in dogs and cats. By incorporating functional compounds such as L-arginine, sodium bicarbonate, hydroxyapatite, and coconut oil, the chew targets harmful bacteria while preserving beneficial oral microbes. This daily-use chew addresses common oral health issues, including plaque buildup, bad breath, and early gum disease, offering pet owners a safe, effective, and practical alternative to traditional brushing.

Technical specifications
  • Functional ingredients: L-arginine, sodium bicarbonate, hydroxyapatite, and coconut oil.
  • Mechanism: Uses prebiotics to selectively modulate the oral microbiome, reducing harmful bacteria without affecting beneficial ones.
  • Applications: Prevents plaque and gingivitis, supports overall oral hygiene.
  • Design: Formulated for daily use with optimal taste and texture for pet acceptance.
Technology readiness level

Currently at Technology Readiness Level 4, this chew has been validated in the lab using a representative bacterial mixture. The next stage involves developing a prototype for animal studies to assess taste, texture, ingredient efficacy, and safety. These trials will help refine the product for commercial readiness and regulatory compliance.


About University of Connecticut

UConn is a comprehensive public research university and the state’s flagship, with its main campus in Storrs and an academic medical center in Farmington. Industry engages through UConn Tech Park—anchored by the Innovation Partnership Building—with shared labs, pilot‑scale testbeds, and advanced prototyping for collaborators. Integration with UConn Health enables clinical collaborations and translation, while Hartford and Stamford campuses connect companies to talent along the New York–Boston corridor; a statewide extension network supports technology adoption. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DOD. A dedicated technology commercialization office and the Technology Incubation Program support IP, licensing, and startup incubation across multiple sites.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.